Showing 361 - 380 results of 1,787 for search '(( 3 c decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.19s Refine Results
  1. 361
  2. 362
  3. 363
  4. 364
  5. 365

    Dynamics of Neisseria gonorrhoeae transmission among female sex workers and clients: A mathematical modeling study by Houssein H., Ayoub

    Published 2024
    “…Increasing symptomatic treatment coverage among FSWs from 0 % to 100 % decreases prevalence from 10.6 % to 4.5 %, 0.8 % to 0.4 %, and 0.3 % to 0.1 %, respectively. …”
    Get full text
    Get full text
    Get full text
    article
  6. 366

    Spray-Dried Proliposome Microparticles for High-Performance Aerosol Delivery Using a Monodose Powder Inhaler by Omer, H.

    Published 2018
    “…Using a two-stage impinger (TSI), fine particle fraction (FPF) values of the proliposomes were higher for mannitol-based formulations, reaching 52.6%, which was attributed to the better flow properties when mannitol was used as carrier. …”
    Get full text
    Get full text
    Get full text
  7. 367
  8. 368
  9. 369

    Morphology, nucleation, and isothermal crystallization kinetics of poly(butylene succinate) mixed with a polycarbonate/MWCNTs masterbatch by Gumede, Thandi P.

    Published 2018
    “…Standard DSC scans showed that the MWCNTs nucleation effects saturated at 0.5 wt% MWCNT content on the PBS-rich phase, above this content a negative nucleation effect was observed. Isothermal crystallization results indicated that with 0.5 wt% MWCNTs the crystallization rate was accelerated, but further increases in MWCNTs loading (and also in PC content) resulted in progressive decreases in crystallization rate. …”
    Get full text
    Get full text
  10. 370

    Proliposome tablets manufactured using a slurry-driven lipid-enriched powders: Development, characterization and stability evaluation by Khan I.

    Published 2018
    “…Proliposome powders were prepared via a slurry method using sorbitol or D-mannitol as carbohydrate carriers in 1:10 or 1:15 w/w lipid phase to carrier ratios. …”
    Get full text
    Get full text
  11. 371
  12. 372
  13. 373
  14. 374
  15. 375
  16. 376
  17. 377
  18. 378
  19. 379
  20. 380